Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Nov 15, 2016
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-11-11+466,141→ 466,141 totalExercise: $0.98Exp: 2026-11-11→ Common Stock (466,141 underlying)
Footnotes (1)
- [F1]This option was granted on November 11, 2016. This option vests in four equal installments over a four-year period from the date of grant, with the first installment vesting on the date that is one year following the date of the grant.